Table 6.
Correlation between clinical variables and imaging findings.
| Pre-treatment | Post-treatment | Values of treatment effect | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PsADECTS score | Iodine uptake | PsADECTS score | Iodine uptake | PsADECTS score | Iodine uptake | |||||||
| Spearman’s ρ | p | Spearman’s ρ | p | Spearman’s ρ | p | Spearman’s ρ | p | Spearman’s ρ | p | Spearman’s ρ | p | |
| VAS | 0.33 | n.s. | 0.54 | <0.05* | 0.28 | n.s. | 0.43 | <0.05* | 0.05 | n.s. | −0.1 | n.s. |
| UA | 0.01 | n.s. | −0.14 | n.s. | −0.26 | n.s. | −0.27 | n.s. | −0.1 | n.s. | −0.04 | n.s. |
| CRP | 0.45 | <0.05* | 0.38 | n.s. | 0.02 | n.s. | −0.04 | n.s. | −0.14 | n.s. | −0.16 | n.s. |
| MMP-3 | 0.31 | n.s. | 0.3 | n.s. | −0.12 | n.s. | −0.15 | n.s. | 0.11 | n.s. | 0.1 | n.s. |
| WBC | 0.34 | n.s. | 0.24 | n.s. | −0.17 | n.s. | −0.23 | n.s. | −0.52 | <0.05* | −0.44 | <0.05* |
| Plt | 0.31 | n.s. | 0.41 | n.s. | 0.29 | n.s. | 0.17 | n.s. | 0.15 | n.s. | 0.13 | n.s. |
| Neu | 0.3 | n.s. | 0.24 | n.s. | −0.04 | n.s. | −0.11 | n.s. | −0.31 | n.s. | −0.36 | n.s. |
| Lym | 0.17 | n.s. | −0.24 | n.s. | 0.13 | n.s. | 0.07 | n.s. | −0.25 | n.s. | −0.04 | n.s. |
| PLR | 0.15 | n.s. | 0.51 | <0.05* | 0.07 | n.s. | 0.03 | n.s. | 0.19 | n.s. | 0.27 | n.s. |
| NLR | 0.14 | n.s. | 0.34 | n.s. | −0.11 | n.s. | −0.12 | n.s. | −0.24 | n.s. | −0.19 | n.s. |
All values represent Spearman’s ρ. *p < 0.05 was considered statistically significant. VAS, Visual Analog Scale; UA, Uric acid; CRP, serum C-reactive protein; MMP-3, matrix metalloproteinase-3; WBC; white blood cell; Plt, Platelets; Neu, Neutrophils; Lym, Lymphocytes; PLR, platelet-lymphocyte ratio; NLR, neutrophil-lymphocyte ratio. CRP was not available in two cases.